Jupiter, Florida-based Jupiter Neurosciences has announced the launch of Nugevia GLO, a dietary supplement designed to support skin health by targeting cellular stress, inflammation and glycation.
According to the company, Nugevia GLO uses the patented active ingredient bucillamine combined with antioxidant vitamins C and E, coenzyme Q10, and plant extracts such as pomegranate and grape seed. The company claims this formulation promotes collagen production, improves skin elasticity, and enhances hydration by working at the cellular level.
Jupiter Neurosciences said that bucillamine, previously researched for neurological and metabolic disorders, helps reduce oxidative stress and protect against cellular damage linked to skin aging. The product is positioned as a “daily skin drink,” which the company claims offers a science-backed approach to supporting skin health from within.
The company also highlighted that Nugevia GLO is part of a broader effort to expand its patented pharmaceutical technology into consumer health applications, beyond its ongoing clinical programs.
Nugevia GLO is now available for purchase directly from the company’s website. Jupiter Neurosciences stated that the product has been developed under rigorous scientific protocols and aims to address skin health through cellular protection and repair.
The launch reflects the company’s strategy to leverage its pharmaceutical research in developing consumer wellness products targeting the underlying causes of visible skin aging.
